Brampton, Ontario, Canada Clinical Trials

A listing of Brampton, Ontario, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 95 clinical trials
featured
16-ME-012-E: Healthy Volunteer Study

Compensation: Up to $1,700 for participation  

Cliantha Research
 (10.0 away) Contact site
  • 1076 views
  • 23 Nov, 2020
  • 1 location
featured
19-JR-001: Healthy Volunteer Study

Compensation: Up to $1,560 for participation

Cliantha Research
 (10.0 away) Contact site
  • 1202 views
  • 22 Dec, 2020
  • 1 location
featured
C3711005  

The study will evaluate the effect of coadministration of a range of doses of DGAT2i with 1 dose of ACCi, on hepatic steatosis and the ability of DGAT2i to mitigate ACCi-induced elevations in serum triglycerides. The study has a 2-part design with sequential conduct of Part 1 and Part 2 …

Aggarwal and Associates Limited
 (2.3 away)
  • 0 views
  • 08 Jul, 2021
  • +9 other locations
featured
Digestive Health for Mature Adults 50+

Research in probiotics continues to offer opportunities for adults with digestive issues, like constipation, to seek assistance with improving their frequency and comfort.  KGK is researching the potential improvements of symptoms of occasional or daily constipation in healthy adults over 50 as a result of an investigational probiotic.Qualified participants will …

KGK Science - 19ANHK Mississauga
 (7.0 away) Contact site
  • 0 views
  • 18 Jun, 2021
  • +1 other locations
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description

Galderma Investigational Site
 (9.4 away) Contact site
  • 21 views
  • 16 Jul, 2021
  • +470 other locations
Study to Assess Effectiveness of GlaxoSmithKline's (GSK's) Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults.

The purpose of this study is to evaluate the effectiveness of 2 doses or 3 doses of GSK's licenced meningococcal group B Bexsero (rMenB+OMV NZ) vaccine and of 2 doses of GSK's investigational combined meningococcal (MenABCWY) vaccine (GSK3536819A) in healthy adolescents and young adults. The immunogenicity and safety will also …

conjugate vaccine
menacwy
vaccination
bexsero
GSK Investigational Site
 (9.4 away) Contact site
  • 0 views
  • 01 May, 2021
  • +100 other locations
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

The purpose of this study is to assess the efficacy of the amivantamab and lazertinib combination, compared with osimertinib, in participants with epidermal growth factor receptor (EGFR) mutation (Exon 19 deletions [Exon 19del] or Exon 21 L858R substitution) positive, locally advanced or metastatic non-small cell lung cancer (NSCLC).

measurable disease
osimertinib
solid tumour
epidermal growth factor
growth factor
William Osler Health System
 (1.6 away) Contact site
  • 27 views
  • 25 Jul, 2021
  • +324 other locations
A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Study CC-93538-EE-001 is a Phase 3, multicenter, multinational, randomized, double-blind, placebo-controlled induction and maintenance study to evaluate the efficacy and safety of CC- 93538 in adult and adolescent participants with eosinophilic esophagitis (EoE). The study will incorporate a 24-week Induction Phase followed by a 24-week Maintenance Phase. Participants will be …

Toronto Digestive Disease Associates Inc
 (10.0 away) Contact site
  • 0 views
  • 02 May, 2021
  • +200 other locations
A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

The primary purpose of this study is to assess the long-term safety of nemolizumab (CD14152) in participants with prurigo nodularis (PN).

Galderma Investigational Site
 (9.4 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +140 other locations
Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

This study will assess the safety, tolerability, and efficacy of Atogepant 60 mg compared with placebo in episodic migraines in participants who previously failed 2 to 4 classes of oral prophylactic treatments.

Aggarwal and Associates Limited
 (2.4 away) Contact site
  • 0 views
  • 19 Jul, 2021
  • +134 other locations